Current assets increased 34.0%
Current assets changed +34.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$438.7M→$587.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AUPH financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital increased 35.7%
Working capital changed +35.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$362.5M→$491.9M4 prior comparisons
Total assets increased 56.5%
Total assets changed +56.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$527.5M→$825.7M4 prior comparisons
Operating income increased 18.9%
Operating income changed +18.9% from the comparable as-filed period.
$29.7M→$35.4M2 prior comparisons
Operating margin moved 176 bp higher
Operating margin changed +176 basis points from the comparable as-filed period.
40.49%→42.25%2 prior comparisons
Research & development increased 97.0%
Research & development changed +97.0% from the comparable as-filed period.
$8.4M→$16.6M2 prior comparisons
Cash & equivalents decreased 37.2%
Cash & equivalents changed -37.2% from the comparable as-filed period.
$72.9M→$45.8M3 prior comparisons
Inventory / revenue moved 873 bp lower
Inventory / revenue changed -873 basis points from the comparable as-filed period.
60.97%→52.24%2 prior comparisons
Revenue increased 13.9%
Revenue changed +13.9% from the comparable as-filed period.
$73.5M→$83.7M2 prior comparisons
Current liabilities increased 26.0%
Current liabilities changed +26.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$76.2M→$96.0M4 prior comparisons
Operating cash-flow margin moved 510 bp lower
Operating cash-flow margin changed -510 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
60.50%→55.40%2 prior comparisons
Gross margin moved 121 bp higher
Gross margin changed +121 basis points from the comparable as-filed period.
88.87%→90.08%2 prior comparisons
Working capital / assets moved 915 bp lower
Working capital / assets changed -915 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
68.72%→59.57%4 prior comparisons
R&D / revenue moved 837 bp higher
R&D / revenue changed +837 basis points from the comparable as-filed period.
11.48%→19.85%2 prior comparisons
Operating cash flow increased 4.3%
Operating cash flow changed +4.3% from the comparable as-filed period.
$44.4M→$46.4M2 prior comparisons
SBC / revenue moved 74 bp lower
SBC / revenue changed -74 basis points from the comparable as-filed period.
8.06%→7.32%2 prior comparisons
Shares outstanding increased 1.6%
Shares outstanding changed +1.6% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
131,840,559→133,998,6607 prior comparisons
Current ratio increased 6.4%
Current ratio changed +6.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
5.76→6.124 prior comparisons
Stock-based compensation increased 3.5%
Stock-based compensation changed +3.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$5.9M→$6.1M2 prior comparisons
Inventory decreased 2.4%
Inventory changed -2.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$44.8M→$43.7M4 prior comparisons
Cost of revenue increased 1.6%
Cost of revenue changed +1.6% from the comparable as-filed period.
$8.2M→$8.3M2 prior comparisons
Working capital increased 33.5%
Working capital changed +33.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$330.7M→$441.4M4 prior comparisons
Current assets increased 32.4%
Current assets changed +32.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$409.0M→$541.3M4 prior comparisons
Total assets increased 57.6%
Total assets changed +57.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$502.6M→$792.3M4 prior comparisons
Current liabilities increased 27.6%
Current liabilities changed +27.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$78.3M→$99.9M4 prior comparisons
Operating income increased 130.7%
Operating income changed +130.7% from the comparable as-filed period.
$20.1M→$46.3M2 prior comparisons
Operating margin moved 2700 bp higher
Operating margin changed +2700 basis points from the comparable as-filed period.
28.69%→55.68%2 prior comparisons
Cash & equivalents increased 239.7%
Cash & equivalents changed +239.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$52.9M→$179.7M3 prior comparisons
Operating cash flow increased 18.8%
Operating cash flow changed +18.8% from the comparable as-filed period.
$44.2M→$52.6M3 prior comparisons
Gross margin moved 229 bp higher
Gross margin changed +229 basis points from the comparable as-filed period.
89.84%→92.12%2 prior comparisons
Research & development increased 75.6%
Research & development changed +75.6% from the comparable as-filed period.
$7.4M→$13.1M2 prior comparisons
Revenue increased 18.9%
Revenue changed +18.9% from the comparable as-filed period.
$70.0M→$83.2M2 prior comparisons
Inventory / revenue moved 1217 bp lower
Inventory / revenue changed -1217 basis points from the comparable as-filed period.
66.43%→54.25%2 prior comparisons
Working capital / assets moved 1009 bp lower
Working capital / assets changed -1009 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
65.80%→55.72%4 prior comparisons
R&D / revenue moved 507 bp higher
R&D / revenue changed +507 basis points from the comparable as-filed period.
10.62%→15.68%2 prior comparisons
Inventory decreased 2.9%
Inventory changed -2.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$46.5M→$45.2M4 prior comparisons
Shares outstanding increased 1.1%
Shares outstanding changed +1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
131,629,546→133,051,1687 prior comparisons
Cost of revenue decreased 7.9%
Cost of revenue changed -7.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$7.1M→$6.6M2 prior comparisons
Operating cash-flow margin moved 3 bp lower
Operating cash-flow margin changed -3 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
63.19%→63.17%2 prior comparisons
Current ratio increased 3.7%
Current ratio changed +3.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
5.23→5.424 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.